¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå : Áúȯ À¯Çüº°, ¼­ºñ½º À¯Çüº°, ¹èÆ÷ ¸ðµåº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Chronic Disease Management Market, By Disease Type, By Service Type, By Delivery Mode, By End User, By Geography
»óǰÄÚµå : 1705700
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,333,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,852,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,075,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀåÀº 2025³â 64¾ï 9,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â±îÁö 158¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö CAGR 13.6%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 64¾ï 9,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR: 13.60% 2032³â °¡Ä¡ ¿¹Ãø 158¾ï 5,000¸¸ ´Þ·¯
±×¸². ¸¸¼º Áúȯ °ü¸® ½ÃÀåÀÇ Áö¿ªº° Á¡À¯À²(%)(2025³â)
Chronic Disease Management Market-IMG1

´ç´¢º´, ¾Ï, ½ÉÇ÷°ü Áúȯ(CVD), ¸¸¼º Æó»ö¼º Æó Áúȯ(COPD), õ½Ä µîÀÇ ¸¸¼º ÁúȯÀº Áö¼ÓÀûÀÎ ÀǷḦ ÇÊ¿ä·Î Çϰí ÀÏ»ó»ýȰÀ» Á¦ÇÑÇÏ´Â Àå±âÀûÀÎ °Ç°­»óÅÂÀÔ´Ï´Ù. ½ºÆ®·¹½º°¡ ¸¹Àº »ýȰÀÌ ÀÌ·¯ÇÑ Áõ»óÀ» °ü¸®Çϱ⠾î·Á¿öÁö°í ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ º¸´Ù ¿ì¼öÇÑ ¸¸¼º Áúȯ °ü¸® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀº º¹¼öÀÇ ¸¸¼º ÁúȯÀ» °¡Áø ³ëÀÎ Àα¸ Áõ°¡, ºñ¸¸°ú ½Ä»ýȰÀÇ º¯È­¿¡ ÀÇÇÑ ´ç´¢º´À̳ª ½ÉÇ÷°ü Áúȯ µîÀÇ »ýȰ ½À°üº´ÀÇ ÀÌȯÀ² Áõ°¡, Áúº´ÀÇ Á¶±â ¹ß°ß°ú Áúȯ °ü¸®ÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ ±â¼ú Áøº¸, ÀÇ·áºñ Áõ°¡¸¦ ¾ïÁ¦Çϱâ À§ÇÑ ´Ù¾çÇÑ Á¤ºÎ³ª ¹Î°£ Á¶Á÷ÀÇ ³ë·Â µîÀÇ ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ±×·¯³ª, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á, ¿ø°Ý ¸ð´ÏÅ͸µ Àåºñ ¹× ¼­ºñ½º µµÀÔ ºñ¿ëÀÇ ³ôÀÌ, °³¹ßµµ»ó±¹¿¡¼­ÀÇ ¼÷·ÃµÈ ÇコÄɾî Àü¹®°¡ÀÇ ºÎÁ· µîÀÌ, º¸´Ù ½Å¼ÓÇÑ º¸±ÞÀÇ ¹æÇذ¡ µÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.º¹¼öÀÇ º´Å¸¦ °ü¸®ÇÏ´Â ÅëÇÕ Ç÷§ÆûÀÇ °³¹ß, AI¿Í ¿þ¾î·¯ºí ±â¼úÀÇ ¿ªÇÒ È®´ë, °³º°È­ Äɾ ´ëÇÑ ÁÖ¸ñ »ó½ÂÀÌ ½ÃÀå ±â¾÷¿¡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.

¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå¿¡¼­ ÁÖ¿ä ±â¾÷À» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷¿¡´Â IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum(A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, Healthwise°¡ Æ÷ÇԵ˴ϴÙ.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå, Áúȯ À¯Çüº°, 2021-2032³â

Á¦6Àå ¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå, ¼­ºñ½º À¯Çüº°, 2021-2032³â

Á¦7Àå ¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå, Àü´Þ ¸ðµåº°, 2021-2032³â

Á¦8Àå ¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°, 2021-2032³â

Á¦9Àå ¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå, Áö¿ªº°, 2021-2032³â

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ºÐ¼®°¡ Ãßõ

Á¦12Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Chronic Disease Management Market is estimated to be valued at USD 6.49 Bn in 2025 and is expected to reach USD 15.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.49 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.60% 2032 Value Projection: USD 15.85 Bn
Figure. Chronic Disease Management Market Share (%), By Region 2025
Chronic Disease Management Market - IMG1

Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through lifestyle changes, like avoiding tobacco and maintaining healthy weight. However, busy schedules and stressful lives have made managing such conditions challenging. This has boosted demand for better chronic disease management techniques. Various technological advancements in remote patient monitoring and growing efforts by governments to improve healthcare infrastructure can drive the market growth in the near future.

Market Dynamics:

Global chronic disease management market growth is driven by factors like growing geriatric population burdened by multiple chronic conditions, increasing incidence of lifestyle diseases such as diabetes and cardiovascular diseases due to obesity and changing dietary patterns, growing awareness about benefits of early disease detection and disease management, technological advances in digital health solutions, and initiatives by various governments and private organizations to curb rising healthcare costs. However, data privacy concerns, high deployment costs of remote monitoring devices and services, and lack of skilled healthcare professionals in developing nations can hamper faster adoption. Development of integrated platforms to manage multiple conditions, expanding role of AI and wearable technologies, and growing focus on personalized care provide lucrative growth opportunities for market players.

Key features of the study:

This report provides in-depth analysis of the global chronic disease management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global chronic disease management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum (A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, and Healthwise

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global chronic disease management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic disease management market

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Chronic Disease Management Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Chronic Disease Management Market, By Disease Type, 2021 - 2032, (USD Bn)

6. Global Chronic Disease Management Market, By Service Type, 2021 - 2032, (USD Bn)

7. Global Chronic Disease Management Market, By Delivery Mode, 2021 - 2032, (USD Bn)

8. Global Chronic Disease Management Market, By End User, 2021 - 2032, (USD Bn)

9. Global Chronic Disease Management Market, By Region, 2021 - 2032, (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â